Search research articles
Contact Us
Filters
Showing results (61-70 of 101) with videos related to
Page
of 11
Sort By:
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1979
[Hemoglobin J Amiens beta 17 (A 14) Lys replaced by Asn. Coincidence of a functionally silent new abnormal hemoglobin and a polycythemia vera (author's transl)]
J Elion, H Wajcman, O Belkhodja-Dunda, et al.
Revue Des Maladies Respiratoires
|
January 1, 1987
[Use of intrapleural doxycycline via lavage-drainage in recurrent effusions of neoplastic origin]
J F Muir, C Defouilloy, S Ndarurinze, et al.
Bulletin Du Cancer
|
January 1, 1992
[Hodgkin's disease associated with HIV infection: clinical characteristics and development. French registry of tumors associated with HIV infection]
S Roithmann, J M Tourani, J A Gastaut, et al.
Haematology and Blood Transfusion
|
January 1, 1990
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia
J L Harousseau, N Milpied, J Briere, et al.
Leukemia & Lymphoma
|
June 1, 1992
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements
F Vuillier, J F Claisse, C Vandenvelde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1990
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly
H Tilly, S Castaigne, D Bordessoule, et al.
Haematology and Blood Transfusion
|
January 1, 1987
Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study
M Marty, E Lepage, H Guy, et al.
Leukemia & Lymphoma
|
March 1, 1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy
N Ifrah, M Hunault, J P Jais, et al.
Leukemia & Lymphoma
|
June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma
G Cartron, L Voillat, B Desablens, et al.
Leukemia
|
June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study
M Hunault-Berger, N Milpied, M Bernard, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 101) with videos related to
Sort By:
Page
of 11
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1979
[Hemoglobin J Amiens beta 17 (A 14) Lys replaced by Asn. Coincidence of a functionally silent new abnormal hemoglobin and a polycythemia vera (author's transl)]
J Elion, H Wajcman, O Belkhodja-Dunda, et al.
Revue Des Maladies Respiratoires
|
January 1, 1987
[Use of intrapleural doxycycline via lavage-drainage in recurrent effusions of neoplastic origin]
J F Muir, C Defouilloy, S Ndarurinze, et al.
Bulletin Du Cancer
|
January 1, 1992
[Hodgkin's disease associated with HIV infection: clinical characteristics and development. French registry of tumors associated with HIV infection]
S Roithmann, J M Tourani, J A Gastaut, et al.
Haematology and Blood Transfusion
|
January 1, 1990
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia
J L Harousseau, N Milpied, J Briere, et al.
Leukemia & Lymphoma
|
June 1, 1992
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements
F Vuillier, J F Claisse, C Vandenvelde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1990
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly
H Tilly, S Castaigne, D Bordessoule, et al.
Haematology and Blood Transfusion
|
January 1, 1987
Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study
M Marty, E Lepage, H Guy, et al.
Leukemia & Lymphoma
|
March 1, 1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy
N Ifrah, M Hunault, J P Jais, et al.
Leukemia & Lymphoma
|
June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma
G Cartron, L Voillat, B Desablens, et al.
Leukemia
|
June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study
M Hunault-Berger, N Milpied, M Bernard, et al.
Page
of 11